233
Views
18
CrossRef citations to date
0
Altmetric
Original Research

Polyanionic carbohydrate doxorubicin–dextran nanocomplex as a delivery system for anticancer drugs: in vitro analysis and evaluations

, , , &
Pages 1487-1496 | Published online: 11 Jul 2011

References

  • HoskinsWJPerezCAYoungRCBarakatRRMarkmanMPrinciples and Practice of Gynecologic Oncology4th edLippincott Williams & Wilkins2005
  • HrusheskyWJMBone marrow suppression from doxorubicin and cis-diamminedichloroplatinum is substantially dependent upon both circadian and circannual stages of administrationAnn N York Acad Sci1982397293295
  • SwainSMWhaleyFSEwerMSCongestive heart failure in patients treated with doxorubicin: A retrospective analysis of three trialsCancer200397112869287912767102
  • SchwartzRGMcKenzieWBAlexanderJCongestive heart failure and left ventricular dysfunction complicating doxorubicin therapy: Seven-year experience using serial radionuclide angiocardiographyAm J Med1987826110911183605130
  • Von HoffDDLayardMWBasaPRisk factors for doxorubicin-induced congestive heart failureAnn Intern Med1979915710717496103
  • ZijlstraJGDe VriesEGEMulderNHMultifactorial drug resistance in an Adriamycin-resistant human small cell lung carcinoma cell lineCancer Res1987477178017843028613
  • KayeSMerrySTumour cell resistance to anthracyclines: A reviewCancer Chemother Pharmacol1985142961032982511
  • NairSSinghSVSamyTSAKrishanAAnthracycline resistance in murine leukemic P388 cells. Role of drug efflux and glutathione related enzymesBiochem Pharmacol19903947237282306280
  • BradleyGJurankePFLingVMechanism of multidrug resistanceBiochim Biophys Acta – Reviews on Cancer1988948187128
  • PatilRRGuhagarkarSADevarajanPVEngineered nanocarriers of doxorubicin: a current updateCrit Rev Ther Drug Carrier Syst200825116118540835
  • GilESLiJXiaoHLoweTLQuaternary ammonium β-cyclodextrin nanoparticles for enhancing doxorubicin permeability across the in vitro blood-brain barrierBiomacromolecules200910350551619216528
  • SubediRKKangKWChoiHKPreparation and characterization of solid lipid nanoparticles loaded with doxorubicinEur J Pharm Sci2009373–450851319406231
  • MissirlisDKawamuraRTirelliNHubbellJADoxorubicin encapsulation and diffusional release from stable, polymeric, hydrogel nanoparticlesEur J Pharm Sci200629212012916904301
  • ParkJFongPMLuJPEGylated PLGA nanoparticles for the improved delivery of doxorubicinNanomed200954410418
  • AtyabiFTalaieFDinarvandRThiolated chitosan nanoparticles as an oral delivery system for amikacin: In vitro and ex vivo evaluationsJ Nanosci Nanotechnol2009984593460319928123
  • EsmaeiliFDinarvandRGhahremaniMHDocetaxel-albumin conjugates: Preparation, in vitro evaluation and biodistribution studiesJ Pharm Sci20099882718273018972321
  • SaremiSAtyabiFAkhlaghiSPOstadSNDinarvandRThiolated chitosan nanoparticles for enhancing oral absorption of docetaxel: Preparation, in vitro and ex vivo evaluationInt J Nanomedicine20116111912821289989
  • AkhlaghiSPSaremiSOstadSNDinarvandRAtyabiFDiscriminated effects of thiolated chitosan-coated pMMA paclitaxel-loaded nano-particles on different normal and cancer cell linesNanomedicine20106568969720172052
  • MajzoobSAtyabiFDorkooshFKafedjiiskiKLoretzBBernkop-SchnürchAPectin-cysteine conjugate: Synthesis and in- vitro evaluation of its potential for drug deliveryJ Pharm Pharmacol200658121601161017331323
  • LeeESNaKBaeYHDoxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumorJ Control Release2005103240541815763623
  • VerdièreACDubernetCNématiFPouponMFPuisieuxFCouvreurPUptake of doxorubicin from loaded nanoparticles in multidrug-resistant leukemic murine cellsCancer Chemother Pharmacol19943365045088137462
  • De VerdièreACDubernetCNématiFReversion of multidrug resistance with polyalkylcyanoacrylate nanoparticles: Towards a mechanism of actionBr J Cancer19977621982059231919
  • WongHLBendayanRRauthAMXueHYBabakhanianKWuXYA mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle systemJ Pharmacol Exp Ther200631731372138116547167
  • EhtezaziTGovenderTStolnikSHydrogen bonding and electrostatic interaction contributions to the interaction of a cationic drug with polyaspartic acidPharm Res200017787187710990208
  • GovenderTEhtezaziTStolnikSIllumLDavisSSComplex formation between the anionic polymer (PAA) and a cationic drug (procaine HCl): characterization by microcalorimetric studiesPharm Res19991671125113110450942
  • KitaevaMVMelik-NubarovNSMengerFMYaroslavovAADoxorubicin-poly(acrylic acid) complexes: interaction with liposomesLangmuir200420166575657915274557
  • TianYBrombergLLinSNAlan HattonTTamKCComplexation and release of doxorubicin from its complexes with pluronic P85-b-poly(acrylic acid) block copolymersJ Control Release2007121313714517630011
  • MargaritisAManochaBControlled release of doxorubicin from doxorubicin/γ-polyglutamic acid ionic complexJournal of Nanomaterials201018
  • PratesiGSaviGPezzoniGPoly-L-aspartic acid as a carrier for doxorubicin: A comparative in vivo study of free and polymer-bound drugBr J Cancer19855268418484074638
  • BogushTSmirnovaGShubinaISyrkinARobertJDirect evaluatlon of intracellular accumulation of free and polymer-bound anthracyclinesCancer Chemother Pharmacol19953565015057533670
  • KwonGSYokoyamaMOkanoTSakuraiYKataokaKBiodistribution of micelle-forming polymer–drug conjugatesPharm Res19931079709748378259
  • JeongY-INahJ-WLeeH-CKimS-HChoCSAdriamycin release from flower-type polymeric micelle based on star-block copolymer composed of poly([gamma]-benzyl-glutamate) as the hydrophobic part and poly(ethylene oxide) as the hydrophilic partInt J Pharm19991881495810528082
  • KataokaKMatsumotoTYokoyamaMDoxorubicin-loaded poly(ethylene glycol)-poly([beta]-benzyl – aspartate) copolymer micelles: their pharmaceutical characteristics and biological significanceJ Control Release2000641–314315310640653
  • OhILeeKKwonHYRelease of adriamycin from poly(I³-benzyl-L-glutamate)/poly(ethylene oxide) nanoparticlesInt J Pharm1999181110711510370207
  • ChenYSynthesis of albumin-dextran sulfate microspheres possessing favourable loading and release characteristics for the anticancer drug doxorubicinJ Control Release19943114954
  • JanesKAFresneauMPMarazuelaAFabraAAlonsoMJChitosan nanoparticles as delivery systems for doxorubicinJ Control Release2001732–325526711516503
  • TanMLFriedhuberAMDunstanDEChoongPFMDassCRThe performance of doxorubicin encapsulated in chitosan-dextran sulphate microparticles in an osteosarcoma modelBiomaterials31354155119836833
  • YangMChanHLLamWFongWFCytotoxicity and DNA binding characteristics of dextran-conjugated doxorubicinsBiochimica et Biophysica Acta – General Subjects199813803329335
  • ShinozawaSFukudaTArakiYOdaTEffect of dextran sulfate on the survival time and mitochondrial function of adriamycin (doxorubicin)-treated miceToxicol Appl Pharmacol19857923533572408357
  • BishtSMaitraADextran–doxorubicin/chitosan nanoparticles for solid tumor therapyWiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology20091441542520049807
  • LamWChanHYangMChengSFongWSynergism of energy starvation and dextran-conjugated doxorubicin in the killing of multidrug-resistant KB carcinoma cellsAnticancer Drugs199910217117810211547
  • LamWLeungCHChanHLFongWFToxicity and DNA binding of dextran-doxorubicin conjugates in multidrug-resistant KB-V1 cells: optimization of dextran sizeAnticancer Drugs200011537738410912954
  • SheldonKMarksABaumalRSensitivity of multidrug resistant KB-C1 cells to an antibody-dextran-adriamycin conjugateAnticancer Res1989936376412475051
  • AngererJSchallerKHAnalyses of Hazardous Substances in Biological Materials7WeinheimWiley-VCH2001
  • RubinSCChemotherapy of Gynecologic Cancers: Society of Gynecologic Oncologists Handbook2nd edBaltimoreLippincott Williams & Wilkins2003
  • TianYRaviPBrombergLHattonTATamKCSynthesis and aggregation behavior of pluronic F87/poly(acrylic acid) block copolymer in the presence of doxorubicinLangmuir20072352638264617269798
  • ChairesJBSatyanarayanaSSuhDFoktIPrzewlokaTPriebeWParsing the free energy of anthracycline antibiotic binding to DNABiochemistry1996357204720538652545
  • HajianRShamsNMohagheghianMStudy on the interaction between doxorubicin and deoxyribonucleic acid with the use of methylene blue as a probeJ Braz Chem Soc200920813991405
  • MichaelisLGranickSMetachromasy of basic dyestuffsJ Am Chem Soc194567712121219
  • KrishnamurthyKVMethods in Cell Wall CytochemistryLLCCRC Press1999